Category Archives: Medicine Wellness Health

Medicine Wellness Health

Evo rocks 2018!

A year in review of Evo Drinks

Evo rocks 2018!

Another year filled by success is coming to an end and as well as the years before the beverage industry is shining yellow and red in 2018! During the year everyone wanted a taste of the delicious Evo Drinks. This included not just sport icons and TV stars. Celebrities walking on the red carpet were screaming for Evo.

A year in review:

January – Annual kick- off marketing event! „Ladies just us!“ – the motto of the dance event at the Motsi Mabuse Taunus dance academy. A day as a tribute to the stronger sex with lots of offerings. The power women were refreshed by Evo Drinks during the dance breaks and because the drinks were the most wanted, two month after this amazing event Evo Drinks has been invited again! Another amazing chance for Evo Drinks: The Stars of Let’s Dance were teaching workshops and were fascinated by the red and yellow cans.
Than another huge success! Evo Drinks has been officially listed at Spar Austria during the first quarter of the year! WOW what an amazing start into 2018!

Now lay back and relax? – Not Evo Drinks!
Right between foodporn and foodielisious, Evo Drinks showed off at the Internorga, a very popular international culinary fair in Hamburg during the 9th till the 13th of March 2018 and recorded another accomplishment!
But not just the North of Germany is fixed by Evo Drinks. In July the most successful event of the year took place! Antenne Vorarlberg Badespass powered by Evo Drinks! The radio station went ahead and did lots of marketing, so the listeners were able to get excited for the drinks. The gigantic pool party for the whole family was crowded! During the day Evo Drinks refreshed the families with cold beverages.
This amount of achievements is magnetic for others and because of that there were rumors about a takeover from PEPSICO. These are simply rumors! The Evo Drinks staying in the own warehouse because that’s where success is bottled in 200 ml Cans. ;)

November 2018, another HIGHLIGHT. The 37th Sportpresseball in the Alte Oper Frankfurt is on! On the red carpet? – Evo Drinks as one of the official sponsors. But camera flashes couldn’t dazzle the Evo brothers. The shining cans were found on the third floor where the action happened! Here Evo Drinks refreshed the celebrities with special cocktails Evo style! It was the second time that the company presented itself on this enormous event and the second time very successful.

For the next year there is a lot on the plate. Amongst other things more listings are planed. One of them will be realised in the first quarter of 2019. Which market that will be is a secret for now, so keep posted on Evo news.

Conclusion:
2018 Evo Drinks prevailed on the market. The company stays on growth course and stars with, all natural POWER into 2019.
At that point a big Thank you to all our partners and amazing supporter!
A special thanks to all of our athletes, we are very proud of you! – You rock!

Die Evo Drinks Group wurde im Jahr 2009 in Oregon gegründet.

Die Entwicklung von Evo Drinks hat in den letzten 2 Jahren alle Erwartungen übertroffen und verfügt derzeit über Niederlassungen und Lizenzpartner in verschiedenen Ländern für die Vermarktung von Evo Drinks. Der Hauptsitz für Europa wurde aus strategischen Gründen in Großbritannien eingerichtet, hierbei handelt es sich um die Evo Drinks Europe Ltd. mit Sitz in Northwood.

Weiterhin verfügt Evo Drinks über Niederlassungen in Deutschland, der Schweiz, Australien, Spanien, Italien, Belgien und Frankreich.

Den Vertrieb bzw. die Distribution von Evo Drinks® wird durch Lizenznehmer übernommen, welche in den einzelnen Ländern auf eigene Rechnung tätig sind. Hierzu wurden Exklusiv-Verträge in der Schweiz, Belgien, Niederlande, Luxemburg, Spanien, Italien, Frankreich, Sri Lanka, Indien, Arabische Emirate, Iran und Irak geschlossen. Insgesamt derzeit in ca. 15 Ländern weltweit und täglich kommen neue Vertriebspartner hinzu.

Wussten Sie eigentlich…. dass in Bezug auf Getränkedosen etwa 70% aller verkauften Dosen der Getränkebranche recycelt werden, bei der Produktion 95% der Energie eingespart wird und jede Dose zu 100% recycelbar und in weniger als 60 Tagen wieder im Verkaufsregal steht ? Nur einige Fakten zur Getränkedose welche die Weltmeere nicht verschmutzt!

Company-Contact
EVO DRINKS
Max Märker
Ahauser Str. 120
46325 Borken
Phone: +49(211) 54 76 14 24
E-Mail: m.maerker@evodrinks.de
Url: http://www.evodrinks.de/

Press
TM 2020 New Media
Rebecca Köstner
Kurfürstendamm 217
10719 Berlin
Phone: 015224244619
E-Mail: rk@2020newmedia.com
Url: http://www.2020newmedia.com/index.html

Medicine Wellness Health

Evo rocks 2018!

A year in review of Evo Drinks

Evo rocks 2018!

Another year filled by success is coming to an end and as well as the years before the beverage industry is shining yellow and red in 2018! During the year everyone wanted a taste of the delicious Evo Drinks. This included not just sport icons and TV stars. Celebrities walking on the red carpet were screaming for Evo.

A year in review:

January – Annual kick- off marketing event! „Ladies just us!“ – the motto of the dance event at the Motsi Mabuse Taunus dance academy. A day as a tribute to the stronger sex with lots of offerings. The power women were refreshed by Evo Drinks during the dance breaks and because the drinks were the most wanted, two month after this amazing event Evo Drinks has been invited again! Another amazing chance for Evo Drinks: The Stars of Let’s Dance were teaching workshops and were fascinated by the red and yellow cans.
Than another huge success! Evo Drinks has been officially listed at Spar Austria during the first quarter of the year! WOW what an amazing start into 2018!

Now lay back and relax? – Not Evo Drinks!
Right between foodporn and foodielisious, Evo Drinks showed off at the Internorga, a very popular international culinary fair in Hamburg during the 9th till the 13th of March 2018 and recorded another accomplishment!
But not just the North of Germany is fixed by Evo Drinks. In July the most successful event of the year took place! Antenne Vorarlberg Badespass powered by Evo Drinks! The radio station went ahead and did lots of marketing, so the listeners were able to get excited for the drinks. The gigantic pool party for the whole family was crowded! During the day Evo Drinks refreshed the families with cold beverages.
This amount of achievements is magnetic for others and because of that there were rumors about a takeover from PEPSICO. These are simply rumors! The Evo Drinks staying in the own warehouse because that’s where success is bottled in 200 ml Cans. ;)

November 2018, another HIGHLIGHT. The 37th Sportpresseball in the Alte Oper Frankfurt is on! On the red carpet? – Evo Drinks as one of the official sponsors. But camera flashes couldn’t dazzle the Evo brothers. The shining cans were found on the third floor where the action happened! Here Evo Drinks refreshed the celebrities with special cocktails Evo style! It was the second time that the company presented itself on this enormous event and the second time very successful.

For the next year there is a lot on the plate. Amongst other things there is a new Evo- member: Ex professional athlete Jürgen Hingsen is the new brand ambassador. Welcome to the Team! Other than that, more listings are planed. One of them will be realized in the first quarter of 2019. Which market that will be is a secret for now, so keep posted on Evo news.

Conclusion:
2018 Evo Drinks prevailed on the market. The company stays on growth course and stars with, all natural POWER into 2019.
At that point a big Thank you to all our partners and amazing supporter!
A special thanks to all of our athletes, we are very proud of you! – You rock!

Die Evo Drinks Group wurde im Jahr 2009 in Oregon gegründet.

Die Entwicklung von Evo Drinks hat in den letzten 2 Jahren alle Erwartungen übertroffen und verfügt derzeit über Niederlassungen und Lizenzpartner in verschiedenen Ländern für die Vermarktung von Evo Drinks. Der Hauptsitz für Europa wurde aus strategischen Gründen in Großbritannien eingerichtet, hierbei handelt es sich um die Evo Drinks Europe Ltd. mit Sitz in Northwood.

Weiterhin verfügt Evo Drinks über Niederlassungen in Deutschland, der Schweiz, Australien, Spanien, Italien, Belgien und Frankreich.

Den Vertrieb bzw. die Distribution von Evo Drinks® wird durch Lizenznehmer übernommen, welche in den einzelnen Ländern auf eigene Rechnung tätig sind. Hierzu wurden Exklusiv-Verträge in der Schweiz, Belgien, Niederlande, Luxemburg, Spanien, Italien, Frankreich, Sri Lanka, Indien, Arabische Emirate, Iran und Irak geschlossen. Insgesamt derzeit in ca. 15 Ländern weltweit und täglich kommen neue Vertriebspartner hinzu.

Wussten Sie eigentlich…. dass in Bezug auf Getränkedosen etwa 70% aller verkauften Dosen der Getränkebranche recycelt werden, bei der Produktion 95% der Energie eingespart wird und jede Dose zu 100% recycelbar und in weniger als 60 Tagen wieder im Verkaufsregal steht ? Nur einige Fakten zur Getränkedose welche die Weltmeere nicht verschmutzt!

Company-Contact
EVO DRINKS
Max Märker
Ahauser Str. 120
46325 Borken
Phone: +49(211) 54 76 14 24
E-Mail: m.maerker@evodrinks.de
Url: http://www.evodrinks.de/

Press
TM 2020 New Media
Rebecca Köstner
Kurfürstendamm 217
10719 Berlin
Phone: 015224244619
E-Mail: rk@2020newmedia.com
Url: http://www.2020newmedia.com/index.html

Medicine Wellness Health

The role and importance of patient involvement in nuclear medicine

(Vienna, December 14, 2018) Patient and Public Involvement and Engagement is defined as a dynamic core democratic principle where people affected by clinical interventions and research studies have the right to have a say in how they are treated and what and how research is undertaken. It is a close working collaboration between health professionals, patients and the public. By introducing patients and public opinions and inputs we immediately have two different viewpoints – the health professionals“ goal of furthering their professional outlook and the patients“ and public practical understanding of their condition and needs. However, little evidence of this trend is seen regarding patient and public involvement in nuclear medicine.
There is a moral argument for patient and public involvement at all levels of research and therapy delivery within nuclear medicine. It therefore follows that decisions over research and therapy services includes those who it affects most. Because of patients“ direct experiences of using nuclear medicine, they have a unique insight into what works for them and what improvements are needed, and should therefore have a voice in developing research and therapy service delivery, including agenda setting, study design, development of patient literature, communication, and ethics etc. Such Involvement in nuclear medicine will lead to enhanced quality of care, improved quality of life and improved outcomes for patients.
Researchers and patient facing staff listening to patient experiences and exchanging information jointly can shape and prioritise the future of nuclear medicine research and clinical management. It is through open and transparent dialogue between patients and health professionals that the patient perspective becomes an integral part of how research and therapies are developed and delivered.
An example of integrated patient and public involvement is a nuclear medicine study at the Institute of Cancer Research in London ( https://www.icr.ac.uk/), investigating dosimetry, to measure low radiation doses from nuclear medicine scanning. There is currently little information and understanding of the effects of patient exposure to low levels of radiation. The initial question was discussed with a patient and public involvement panel, who not only prioritised the study, but shaped the design, developed the funding application, Patient Information Sheets, consent forms, and patient recruitment. A patient member of the panel acted as a live phantom to test the studies standard operating procedures of the various SPECT and PET/CT procedures, before the introduction of recruited patient participants. As the study progressed, the patient and public work scope developed to include, patient recruitment, dissemination of findings, data collection, and attendance at monthly steering group meetings, thereby providing total integration with the study team throughout the life of the study.
Nuclear medicine has seen an evolution in theranostics, a concept which involves both the diagnostic and therapeutics, initiating patient tailored treatments, reducing multi-step procedures, reducing delays in treatment and improving patient care.Nuclear medicine and molecular imaging will expand its role in early diagnosis and treatment of diseases becoming a driving force in personalized medicine using theranostic concepts.
Theranostics is low on public awareness. Reducing public concern about emerging therapies can only be overcome by raising public awareness and involving patients and the public in the pre-delivery process.
Patients‘ awareness of medical imaging was lowest in their understanding of nuclear medicine examinations. 22% of patients said they knew the definition of ionizing radiation (78% didn“t know), 35% stated that CT used it, 30% said MRI used it, 41% incorrectly identified sterility as a risk, 21 % incorrectly identified acute radiation sickness as a risk, 39% of patients indicated that all of these medical imaging tests use ionizing radiation and an equal percent said none of these tests use ionizing radiation. Of patients who claim to understand ionizing radiation, 48% incorrectly stated MRI uses it.
This information reveals the low level of health literacy and patient and public awareness of nuclear medicine and the importance of future patient involvement and collaborations. The objective now must be to increase awareness of patient and public involvement within the nuclear medicine research and therapeutics community and involve patients and the public in nuclear medicine studies and therapy improvements. The European Association of Nuclear Medicine (EANM) is strongly commited to involving and engaging patients and the public in the rapidly expanding field of nuclear medicine, creating collaborations with patient and public contributors as decision making partnerships and co-creators in research and delivery of therapies.

Presseagentur für Medizinthemen

Contact
impressum health & science communication
Frank von Spee
Hohe Brücke 1
20459 Hamburg
Phone: 040 31786410
E-Mail: vonspee@impressum.de
Url: http://www.impressum.de

Medicine Wellness Health

From Vision to reality

Functional diagnostic of small vessels can prevent perfusion damages

From Vision to reality

Retinal Vessel Analysis

In every organ a system of very small blood vessels (the so-called microcirculation) is doing an important job to keep us healthy. The changing blood supply and the exchange of metabolites and oxygen according to varying demands in different tissue areas is organized by complex regulatories in the vessel diameters. If the work of the microcirculation is impaired, vessel diseases arise including well-known harm for our health.
Imedos Systems GmbH has investigated and developed a trendsetting and worldwide unique technology, the Dynamic Vessel Analysis, together with physicians and researchers of the Institute of Biomedical Engineering and Informatics of the Technical University of Ilmenau. „This technology uses light to look inside the eye at the blood vessels of the retinal microcirculation. By applying flickering light we can investigate the vessel function and their regulation based on the vessel diameter changes. So we can observe the smallest vessels of man live at work.“ Dr.-Ing. W. Vilser, CEO of Imedos Systems GmbH explains. „With the previous examination techniques the ophthalmologist can usually detect damages. Our technology, however, is capable of detecting functional disorders leading to vessel diseases long before damages are present.“ This is creating a unique prerequisite for on time and controlled prevention of vascular diseases of the retina, e.g. glaucoma.
Studies also show that the function of retinal vessels reflect general vessel changes of the microcirculation which can be found in other organs, e.g. brain and heart. These parts of the microcirculation are not easily accessible. They can be examined via the eye, though. This is providing a wide range of application of the Imedos technology for the entire vascular medicine far beyond ophthalmology.

The microcirculation of the retina is an excellent window to the heart and the brain. Retinal vessels offer the unique opportunity to be examined in vivo and non-invasively and to provide valuable information about the condition of the body“s microcirculation. Imedos uses those characteristics of the ocular transparency to analyse retinal arteries and veins. Backed by several decades of research and development work, Imedos has become an established supplier of analytical systems for retinal vessels.

Company-Contact
Imedos Systems GmbH
Benedikt Krauß
Am Nasstal 4
07751 Jena
Phone: 03641639624
E-Mail: b.krauss@imedos.de
Url: http://www.imedos.de

Press
Imedos Systems GmbH
Annekathrin Härter
Am Nasstal 4
07751 Jena
Phone: 03641986953
E-Mail: a.haerter@imedos.de
Url: http://www.imedos.de

Medicine Wellness Health

TAITRA Presents Top Products at MEDICA 2018

TAITRA Presents Top Products at MEDICA 2018

The Taiwan External Trade Development Council (TAITRA) promotes the sale of Taiwanese products at home and abroad. At today’s MEDICA press conference, TAITRA focused on particularly innovative products from the fields of medical technology and e-health.

Düsseldorf, 13 November 2018
Five Taiwanese exhibitors took the opportunity to present their latest product innovations to international trade journalists. At the invitation of TAITRA, representatives from HTC, Taiwan Main Orthopedics, AmCad BioMed, BAUI Biotech and Rehabotics Medical Technology stood before an engaged audience and presented insights into the ambitious research and development work in Taiwan as well as their latest product innovations.

For example, the HTC Group relies heavily on virtual reality and impresses in two respects with the VR glasses VIVE. First, VIVE provides access to the first anatomical 3D atlas. On the other hand, the glasses have already achieved initial successes in the therapy of the fear of heights. Absolutely innovative is the fact that the therapy is accompanied by a virtual trainer instead of a human therapist.

The Virtual Dissection Table and the surgical glasses from Taiwan Main Orthopedics are also highly technical. The treatment table, which displays fully anatomical structures and, is suitable both for teaching purposes and for planning surgical interventions. The intelligent surgical spectacles complement the range and enable doctors to partially look into the patient’s body during a minimally invasive procedure and to display a 3D model of nerves and vessels.

AmCad BioMed Corporation is countering obstructive sleep apnea syndrome with a promising new diagnostic device. The AmCAD-UO consists of a positioning system and computer-aided recognition software. After only ten minutes, the AmCAD-UO provides accurate results and thus ensures efficiency and flexibility in treatment.

After two years of research and development, BAUI Biotech launches the NOVA Minimally Invasive System, which can be used to optimize surgical procedures on the spine. Both the patient and the surgeon benefit from the versatile small screw. The NOVA system effectively stabilizes the spinal column using polyaxial screws with long, fragile blades.

Rehabotics Medical Technology Corporation presents an innovative robotics product. The Mirror Hand was developed to support and accelerate the rehabilitation of the hands, for example after strokes, and to provide patients with practical help in coping with their everyday lives. Weighing only 750 grams, it is by far one of the lightest robotic rehabilitation devices for the hand.

Taiwan relies on technological progress
For many years, Taiwan has enjoyed an excellent reputation as a location for the manufacture of high-quality consumer electronics and medical technology equipment, which the small country has now been able to develop into a significant competitive advantage. TAITRA is committed to those companies that are entering the market with particularly innovative ideas and acts as a partner, mediator and consultant when it comes to initiating and concluding transactions between Taiwanese companies and customers at home and abroad. At the TAITRA joint exhibition stand at the current MEDICA, 15 companies present their new products, which have received the „Taiwan Excellence Award“.

About TAITRA:
TAITRA was founded in 1970 as a non-profit trade promotion organization. Supported by the Taiwanese government, TAITRA opens up new national and international sales markets for member companies from various sectors. TAITRA has created the „Taiwan Excellence“ label, which is awarded every year to particularly innovative products or companies. TAITRA is headquartered in Taiwan’s capital Taipei. The organization has a total of 61 branches worldwide. In Germany, TAITRA has two offices in Düsseldorf and Munich.

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

TAITRA boasts a well-coordinated trade promotion and information network of over 1,300 trained specialists stationed throughout its Taipei headquarters, four local branch offices in Hsinchu, Taichung, Tainan and Kaohsiung, and 60 overseas branch offices worldwide. Together with its sister organizations, Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

Company-Contact
Taiwan External Trade Development Council
Frances Lin
Immermannstr. 33
40210 Dusseldorf
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pk/

Press
DRILLING GmbH
Ben Giese
CelsiusStr. 43
53125 Bonn
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pc/

Medicine Wellness Health

biolitec® at Medica 2018: 10 years ELVeS® Radial® laser therapy and excellent healing successes in proctology and urology with LEONARDO® lasers

10 years ELVeS® Radial® procedure – Studies prove excellent healing rates of biolitec procedures for coccyx fistulas and BPH – New laser fiber „Sharp tip“ specially developed for microsurgical procedures – biolitec® at Medica Hall 10 Stand H46

biolitec® at Medica 2018: 10 years ELVeS® Radial® laser therapy and excellent healing successes in proctology and urology with LEONARDO® lasers

(Source: biolitec®)

Jena, November 09, 2018 – The laser pioneer biolitec® set standards when it developed the ELVeS® Radial® method for the minimally invasive endovenous treatment of varicose veins and launched it on the market in 2008. The next revolution followed in 2012 with the ELVeS® Radial® 2-ring fiber, which was expanded to include two light rings that divide the laser power into two equal parts of 50% each and thus produce even more homogeneous radiation. The side effects can be reduced even further with a very high occlusion rate, further minimizing postoperative pain and ecchymosis. Since 2017, the ELVeS® Radial® 2ring slim fiber with a diameter of only 1.3 mm has been available and thus offers the possibility of treating perforating veins and side branches as well as more complicated anatomical structures and stripping relapses in addition to the larger trunk veins.

With the biolitec® therapies FiLaC® (Fistula-tract Laser Closure for anal fistulae), SiLaC® (Sinus Pilonidalis treatment) and LHP® (LaserHemorrhoidoPlasty for hemorrhoids) for proctology, biolitec® has developed innovative minimally invasive methods in which the tissue is irradiated from the inside with the laser energy and thus gently destroyed. The treatment of coccyx fistulas can achieve a cure rate of over 90% after the first treatment with the new, particularly gentle minimally invasive method SiLaC® from biolitec®. This was the result of a study carried out on 237 patients at the gastroenterological department of the University Hospital Ioannina, Greece, and published in June 2018.

About one third of all women over 30 years of age are affected by myomas. The gentle and, above all, uterus-preserving treatment of myomas is of great importance, especially for women who wish to have children. The HOLA® laser therapy by biolitec® is a gentle and effective treatment alternative by means of laser, which can be performed on an outpatient basis and under local anesthesia. Myomas can be enucleated quickly and gently with MyoFiber® glass fibers in different designs. The laser energy avoids the contraction of the uterine muscles and can therefore be used without or under minimal local anesthesia. The extremely gentle procedure with continuous irrigation with saline solution ensures a quick return to normal activities.

In urology the minimally invasive laser treatment LIFE of biolitec® with its channel technique is particularly suitable for the treatment of benign prostatic hyperplasia in high-risk patients. Urologists at Harasanshin Hospital Fukuoka in Japan helped develop this special channel technique and operated on 26 patients who either suffer from diabetes and/or have to take anticoagulants. With the channel technique, surgery could be performed much faster than with conventional procedures – on average 1 hour – and a large cavity could be achieved without having to remove the tissue completely. Side effects such as swelling, dysuria or retention, which are particularly common in large glands, did not occur.

Already at the beginning of this year biolitec® presented its „Sharp tip“ laser fiber especially for microsurgical procedures. This needle-shaped fiber tip is the first laser fiber worldwide that can cut and coagulate without coupled or adapted separate endings. The surgeon can easily guide the glass fiber and thus in most cases completely replace the classic scalpel. This enables even safer handling compared to conventional laser systems. The „Sharp tip“ fiber is the first laser scalpel made of a homogeneous piece of glass fiber that can be used, for example, to perform slip-eye operations simply and precisely.

The biolitec® team presents at this year’s Medica in Dusseldorf at booth H46 in hall 10 not only the above mentioned innovations but also the complete range of the proven LEONARDO® laser family.

The LEONARDO® laser family includes the lasers of the LEONARDO® Dual series in 45 watt, 100 watt and 200 watt strengths, which are all characterized by the stepless use of the two wavelengths 980nm and 1470nm during treatment. These lasers are the most versatile medical lasers available on the market today. They are suitable for phlebology and proctology as well as minimally invasive surgery in urology, gynecology, ENT, orthopedics, thoracic surgery and pneumology, esthetic surgery and ophthalmology. The innovative LEONARDO® Mini completes the laser family. This device, which weighs just 900 grams, is available in a version with a wavelength of 1470 nm and as LEONARDO® Mini Dual with two wavelengths of 980 nm and 1470 nm. The small laser can also be used mobile in the established biolitec® treatment methods for venous diseases, haemorrhoids, fistulas, a broad spectrum of ENT diseases, in urology, gynecology and orthopedics.

About biolitec
biolitec® is one of the world’s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world’s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®’s field of business. More information available at www.biolitec.com

Contact
biolitec
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Medicine Wellness Health

Maisense to Showcase Smart Cardio Monitoring Solution at MEDICA 2018

Maisense to Showcase Smart Cardio Monitoring Solution at MEDICA 2018

Smart Cardio Monitoring with Maisense Freescan

Hsinchu, Taiwan Nov 7th, 2018 – Maisense, an innovative startup, devoted to stroke prevention, announced its attendance at the MEDICA 2018, in Düsseldorf, Germany from November 12th to 15th. Besides showcasing its solution on Stand B26, Hall 11, the company will also present at the „Taiwan Biomedical Solution Spotlight“ in room 814, Hall 8B, as well as a presentation at MEDICA Connected Healthcare Forum.

Over 5,000 exhibitors from almost 70 countries are expected to attend MEDICA and digital medicine remains a leading topic this year. Maisense is honored to be part of this distinguished gathering to showcase their achievements in cardiovascular care.

Maisense is keeping pace with the current trend. Bach Chen, Vice President of business development, Maisense, will deliver an insightful presentation titled „A mobile device to take multiple cardiovascular parameters simultaneously“ at the MEDICA Connected Healthcare Forum on November 15th. The MEDICA Connected Healthcare Forum provides a platform for showcasing innovative Internet of Things solutions that are transforming the healthcare industry. „We are excited to share this telecardiology system which is to simplify the measurement procedure for patients,“ said Bach Chen.

Not only does Maisense improve the processes of measurement through the palm-sized „Freescan“ device, but it also enables patients to easily manage their own health by monitoring and analyzing their own vital signs using the intelligent „myFreescan“ App. Patients can observe many features on myFreescan, such as a trend view for historical blood pressure measurements, artery age, AFib/ arrhythmia screening, and ECG/pulse waveform viewing. If the patient has activated this feature, an instant doctor“s advice can be sent through the Patient Care System if further care is needed. Maisense is the world“s first company to provide an all-in-1 solution to screen the top 3 causes of stroke: arterial stiffness, hypertension, and atrial fibrillation in single device

How important the monitoring of these values is for early detection and which devices can be used for measurements explains Prof. Dr. med. Med. Thomas Wendt, who also mentions Maisense Freescan as an easy-to-use device, without the need of additional applying electrodes on the patient“s chest, in a recent broadcast of „Service: Gesundheit“ in ARD (minute 00:17 in the video, available in the ARD library).

The myFreescan APP has been selected as one of the 10 finalists in the 2018 MEDICA APP Competition. „This recognition as a top 10 finalists fuels our commitment to provide patients and doctors with a better way for chronic disease management and stroke prevention,“ said Benjamin Chiu, CEO, Maisense. The MEDICA APP Competition is not only awarding stand-alone-apps, but rather wellthought-out overall solution for the day-to-day use of patients, doctors and clinics. The top ten solutions will be presented at the MEDICA Connected Healthcare Forum, Hall 15C24 on Nov. 14 from 3pm.

Maisense is honored to also have been selected as one of the most innovative manufacturers and solution providers for the „Taiwan Biomedical Solution Spotlight“ in room 814, Hall 8B, on Nov. 14. Maisense will be on the stage to demonstrate the cardiovascular solution and seeking opportunity for further cooperations. The company is looking for both partners to grow its European channel as well as for Digital Health SI (System Integration) partners.

In addition to product demos for Freescan, myFreescan and the Patient Care System, the Maisense experts are available on Stand B26, Hall 11 to discuss atrial fibrillation detection and the latest results of clinical studies in Europe and Taiwan.

Freescan is now available in Germany at Mindtec( https://www.mindtecstore.com/Maisense-Freescan-Cardiovascular-Monitor) and ME Health CHECK( https://www.mehealthcheck.de/maisense-freescan-bestellen/16/freescan-ihr-persoenliches-blutdruckmessgeraet-zur-herz-kreislauf-kontrolle?c=16). Maisense is looking for distributors in European Union, Asia, and Middle East.

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/

Medicine Wellness Health

Made in Taiwan: improved medical outcomes – MEDICA 2018

The Taiwan External Trade Development Council – TAITRA – presents an elite group of 15 companies at this year’s MEDICA.

Made in Taiwan: improved medical outcomes - MEDICA 2018

Taiwan is a country founded on technology and the relentless drive for innovation. It benefits from the ambitions of its individual researchers, their institutes and companies and from the engagement and support from the Taiwan External Trade Development Council – TAITRA. At this year“s MEDICA, TAITRA presents an elite group of 15 companies – the recipients of TAITRA’s Taiwan Excellence awards – displaying technology to improve efficiency, process and, ultimately, outcomes to the world“s doctors, caregivers, and patients.

The world’s population is aging and becoming more connected. This fact is of utmost importance to Taiwan; its commercial sectors are focused on issues associated with a citizenry maturing in-step with the West. Rehabotics Medical Technology Corporation has just brought an exceptional aid to the market, MirrorHand, which enables robot-assisted rehabilitation of the hands after a stroke. Weighing only 750 grams, it is by far the lightest robotic rehabilitation device for the hand. The mirrored motion transferred from healthy to compromised hand and the programmable passive motion rehabilitation functions support neuromuscular regeneration.

Some unique technologies are just as beneficial at either end of life. The Opro9 Smart Diaper from Civicloud is an example. By offering a diaper with networked moisture monitoring, this technology is an excellent low-cost, multifunctional device. Whether in a NICs unit where renal function monitoring is a key aspect to positive outcomes, to an assisted living center where the care must remain efficient but responsive and flexible, this simple system can alert staff to needs of each patient and ensure an exceptional quality of care while offering valuable data-points into the EHR.

The ability for doctors to reach rapid, accurate conclusions is key to diagnosis and continued evaluation. Leltek Inc. offers this through a best-in-class cordless ultrasound subsystem. Of particular interest is their system’s bring-your-own-device compatibility, its ultra-light design at only 330 grams, and the exceptional battery life of three hours – overcoming the issues associated with previous cordless ultrasound solutions.

Another company featured through Taiwan Excellence, AmCad, leverages existing ultrasound diagnostic equipment to achieve the most cost-effective sleep apnea (OSA) diagnosis. As the understanding of the denigrating effects this condition plays in the general population becomes established, AmCad’s UO system delivers standardized ultrasound-head positioning and output data analysis to achieve an accurate diagnosis within 10 minutes on a fully awake patient, thereby eliminating the need for expensive overnight evaluation.

These Taiwan Excellence recipients and others organized by TAITRA will be presented during the MEDICA in Dusseldorf, Germany, from November 12th through the 15th in hall 17 Stand A61. All are interested in realizing opportunities for technological cooperation and business development with the global medical community. Hosts are on-hand and individual tours are available to meet your goals.

Founded in 1970 to help promote foreign trade, the Taiwan External Trade Development Council (TAITRA) is the foremost non-profit trade promotion organization in Taiwan. Jointly sponsored by the government, industry associations, and several commercial organizations, TAITRA assists Taiwan businesses and manufacturers with reinforcing their international competitiveness and in coping with the challenges they face in foreign markets.

TAITRA boasts a well-coordinated trade promotion and information network of over 1,300 trained specialists stationed throughout its Taipei headquarters, four local branch offices in Hsinchu, Taichung, Tainan and Kaohsiung, and 60 overseas branch offices worldwide. Together with its sister organizations, Taiwan Trade Center (TTC) and Taipei World Trade Center (TWTC), TAITRA has created a wealth of trade opportunities through effective promotion strategies.

Company-Contact
Taiwan External Trade Development Council
Frances Lin
Immermannstr. 33
40210 Dusseldorf
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pk/

Press
DRILLING GmbH
Ben Giese
CelsiusStr. 43
53125 Bonn
Phone: +49 (0)228 / 919 37 -66
E-Mail: taiwanexcellence@agentur-drilling.de
Url: https://www.taiwanexcellence2018.de/pc/

Medicine Wellness Health

Uwe Diegel joins healthbank

Health database platform healthbank with new product manager – Diegel has been at the forefront of international changes in healthcare technology for the last 30 years

Uwe Diegel joins healthbank

Uwe Diegel

healthbank, the innovative platform for health data management in Switzerland, is happy to announce the arrival of Uwe Diegel in the role of Head Product Management product manager. Uwe Diegel was a concert pianist until the age of 26 and, following an accident that partially restricted movement in right arm, started a new career in medical diagnostics, quickly developing a particular interest in chronic diseases such as hypertension, asthma and diabetes. His intense scientific curiosity has led him not only to develop new technologies in these fields, but also to interest himself to field of medical manufacturing, industrial design and artificial intelligence.

Uwe is today considered to be a foremost expert in the field of blood pressure management, diabetes, asthma and in the manufacturing of medical diagnostics devices. In 2009, Uwe got interested in connected health as a means of providing better patient management and became involved in iHealth, the world leader in the field of connected health. Uwe served as CEO of iHealthLabs Europe until 2016. He left iHealth in 2016 to focus on health data management research.
Uwe Diegel has been at the forefront of international changes in healthcare technology for the last 30 years. His drive and passion for innovative technology have driven major changes in perception about healthcare. He has driven the manufacturing of medical devices to new horizons by forcing new practices in manufacturing and innovation. An internationally recognized expert in the management of cardiovascular disease and diabetes, he is continuously looking for better solutions to improve outcomes for patients. He has for the last few years spearheaded the dissemination and acceptance of connected health as a tool for providing better solutions for patients.
According to Uwe Diegel, „the creation of a new model of health and healthcare is the greatest single business opportunity of our lifetimes, and it will be accompanied by profound and lasting cultural change. Connection is everywhere and anything that can be connected will be connected. Connection is simply a natural evolution of technology. Every day, an average human being generates 500 megabytes of data, and now, most of this data is wasted. With healthbank, we expect to turn this data into something tremendously valuable financially, but more importantly tremendously valuable for medical research. Healthcare management is not the future of medicine, but its actual present. Tomorrow“s healthcare systems will consist of solutions, not for everyone, but indeed for every single one of us. And this is what we want to do with healthbank“.

About healthbank
healthbank is the world’s first citizen-owned, neutral and independent health data transaction platform that enables peo-ple to share their data in a secure and privacy compliant way with other partners. healthbank connects data sources of all kinds from the entire health sector and rewards participants to share their health data for research purposes. Based in Switzerland, healthbank stands for Swiss neutrality, trust and data protection and enables participating citizens, research-ers and organisations with large amounts of data to network with each other. Thus, the value of health and medical data can be optimally tapped on this independent, global health platform. healthbank promotes innovations in health care, from prevention to cure, at a more reasonable price and of better quality, for the benefit of individuals and society.
www.healthbank.coop

Company-Contact
healthbank
Pauline Geniets
Blegistrasse 17a
6340 Baar
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Press
healthbank
Roger Huber
Gartenstrasse 36
8002 Zürich
Phone: +41 44 202 61 60
E-Mail: roger.huber@huber-media.ch
Url: http://www.healthbank.coop

Medicine Wellness Health

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Maisense Presents AI-based Solution to Screen Atrial Fibrillation in Early Phase to Improve Stroke Prevention

Freescan: the AI-based solution for stroke prevention (Source: © Maisense)

Hsinchu, Taiwan Oct 9th, 2018 – Maisense, an innovative startup, devotes itself to stroke prevention. The company now introduces an AI-based solution that can screen stroke through early detection of atrial fibrillation (AFib) which will also be presented at MEDICA 2018 November 12-15 in Düsseldorf, Germany at booth B26/Hall 11 and is a finalist for the MEDICA App COMPETITION.

Every four minutes, someone dies of stroke. Stroke is also a leading cause of long-term disability. Stroke is even called the „silent killer“ because it often come without any warning signs. However, up to 80% of stroke could be preventable by monitoring the major risk factors of stroke at an early stage.

13% of strokes are classified as hemorrhagic stroke. When the arteries of the brain weaken or break, allowing for blood to spread in the brain tissues, hemorrhagic strokes occur. They are most often caused by chronically hypertension. Up to 87% of strokes are classified as ischemic. An ischemic stroke occurs when a clot or a mass blocks a blood vessel, cutting off blood flow to a part of the brain. There are two main risk factors of ischemic strokes: arterial stiffness and atrial fibrillation (AFib).

A research, „Changes in arterial stiffness independently predict stroke in patients with essential hypertension,“ published in 2018 European Society of Cardiology (ESC), shows a demonstrated association and prediction between arterial stiffness and stroke for essential hypertension patients. The Framingham Heart Study (FHS) identified common factors and characteristics contributed to cardiovascular disease. Low-density lipoprotein (LDL), also called the „bad cholesterol“, is a notable enemy of arterial elasticity and fosters arterial stiffness. High LDL level raises the chances of a heart attack because it deposits in the walls of blood vessels that narrows the arteries or even clog. Other risk factors such as age, hypertension, smoking and diabetes are highly related to cardiovascular diseases.

It’s worth noting that patients with AFib have a five-fold increase in risk of stroke compared to those without. It affects 4.5 million people living in the European Union, and accounts for approximately one-third of hospitalizations for cardiac rhythm disturbances. The European Heart Rhythm Association (EHRA), who published the aforementioned numbers, released a classification system of AFib-related symptoms in 2014. EHRA also stressed the fatal consequence even if AFib symptoms are not noticeable to patient or they may not feel uncomfortable. „Since an AFib episode can come and go, there may be many patients undetected and therefore they didn“t receive timely treatment. That“s why we take AFib screening seriously as a key measurement for stroke prevention,“ said Benjamin Chiu, CEO of Maisense.

AFib is usually diagnosed on an ECG but if a patient“s symptoms don“t occur while he sees his doctor or if they are back to normal at this point of time, the doctor would not be able to give advice properly. As a result, Maisense presented the Freescan device and the myFreescan App, which deliver an all-in-1 solution, utilizing artificial intelligence (AI) for early AFib detection, arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity, and blood pressure monitoring in a single device. Users adopting Maisense’s solution can assess their risk level of strokes anytime.

From the patient“s perspective, the solution makes it very easy to measure and record all these biomedical signals at any time. Patients can monitor their own health conditions and take action at an early stage. Through the web-based Patient Care System, doctor can also be informed immediately when abnormal incidents occur – if a patient activated this function under doctor-patient privilege. It also provides sufficient data for doctors to make assessment quickly. The option does not only help to avoid unnecessary healthcare spending and time investments but also improves the service efficiency.

As Apple announced its Watch Series 4, which can record ECG and has received FDA approval, it is believed that more and more people are noticing the importance of irregular heart rhythm detection. Maisense is the world“s first company to provide an all-in-1 solution to screen the top 3 causes of stroke: arterial stiffness, hypertension, and atrial fibrillation in one single device. Maisense“s Freescan has received EU CE medical certification and is now available in Germany. Maisense will also present the solution at the upcoming „MEDICA 2018“ trade fair on November 12-15 in Düsseldorf, Germany, in Hall 11/ booth B26. Freescan has been selected as one of the 10 finalists in the MEDICA App COMPETITION ( https://www.medica-tradefair.com/cgi-bin/md_medica/lib/pub/tt.cgi/MEDICA_App_COMPETITION.html?oid=46182&lang=2&ticket=g_u_e_s_t). The top ten solutions will be presented at the MEDICA Connected Healthcare Forum, Hall 15C24 on Nov. 14 from 3pm.

For more information on pricing and the availability of Freescan, please visit Mindtec: https://www.mindtecstore.com/Maisense-Freescan-Cardiovascular-Monitor
and ME Health CHECK: https://www.mehealthcheck.de/maisense-freescan-bestellen/16/freescan-ihr-persoenliches-blutdruckmessgeraet-zur-herz-kreislauf-kontrolle?c=16

About TITAN Commerce
TITAN Commerce“s wide product range includes state-of-the-art biotechnology, wearables and professional Sportswear technologies from various well-known biofeedback, neurofeedback and wearable manufacturers. The goal of TITAN Commerce is to provide end-customer with the most technically innovative products to help them to deal with their daily impact of external influences such as stress, exhaustion, concentration and attention deficits. For more information, please visit: www.titan-commerce.com

About appPeople
Founded in 2011, appPeople GmbH develops and distributes mobile applications and medical devices. The innovative products enable the regular collection of relevant health parameters, helping to better assess treatment outcomes and improve users‘ quality of life. The dynamically growing company works with partners in Europe and Asia and is one of the most successful and creative names in its field. For more information, please visit: www.mehealthcheck.de

About Maisense:
Maisense is an innovative startup working in non-invasive medical cardiovascular monitoring for personal use, combined with artificial intelligence software for stroke prevention including AFib/arrhythmia/artery stiffness detection for professional physician use. Founded in 2012, Maisense was granted the award for „Best Investment Potential“ by Taiwan“s Ministry of Economic Affairs. Maisense“s Freescan is the world first cuffless blood pressure monitor measuring directly from wrist pulse and it has received EU CE medical certification. It has been honored with the 2015 National Innovation Award in Taiwan, as well as ranking second among the Top 10 Innovative Health Products at the Arab Health 2016 fair in Dubai. In 2017, it has received the „Taiwan top 10 coolest innovative startups award“ from the Ministry of Science and Tech in Taiwan. For more information, visit www.maisense.com

About GLORIA-Semicon:
„GLORIA-Semicon“ – (Global Research & Industry Alliance Semiconductor) of Taiwan Ministry of Science & Technology is a platform that promotes high value-added and cross-field innovative products and services, and also dedicates in exploring and expanding the opportunities for members“ pioneering design to connect with Taiwan industry and academy resources. For more information, please visit http://riact.nctu.edu.tw/

GLORIA-Semicon is now coordinating a special interest group (SIG) for biomedical devices providers. Connections in between medical doctors, clinical trials as well as interdisciplinary researches are being sponsored by Taiwan government. We welcome international partners and jointly explore new businesses and channels especially in Chinese communities.

Dedication of GLORIA-Semicon:
– Allying global entrepreneurs with Taiwan semiconductor eco-system
– Providing one-stop services
– Facilitating global entrepreneurs in Taiwan to connect with local resources
– Collaborating with excellent academic groups in technical development

Company-Contact
Pressoffice Maisense
Wibke Sonderkamp
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.40
E-Mail: wibke@gcpr.net
Url: http://www.maisense.com/en/

Press
Pressoffice Maisense
Laura Lehmann
Münchner Str. 14
85748 Garching bei München
Phone: +49.89.360363.52
E-Mail: laura@gcpr.net
Url: https://www.gcpr.de/